Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers
PM Glassman, ED Hood, LT Ferguson, Z Zhao… - Advanced drug delivery …, 2021 - Elsevier
Drug delivery research pursues many types of carriers including proteins and other
macromolecules, natural and synthetic polymeric structures, nanocarriers of diverse …
macromolecules, natural and synthetic polymeric structures, nanocarriers of diverse …
Drug delivery by red blood cells: vascular carriers designed by mother nature
VR Muzykantov - Expert opinion on drug delivery, 2010 - Taylor & Francis
Importance of the field: Vascular delivery of several classes of therapeutic agents may
benefit from carriage by red blood cells (RBC), for example, drugs that require delivery into …
benefit from carriage by red blood cells (RBC), for example, drugs that require delivery into …
Non-genetic engineering of cells for drug delivery and cell-based therapy
Cell-based therapy is a promising modality to address many unmet medical needs. In
addition to genetic engineering, material-based, biochemical, and physical science-based …
addition to genetic engineering, material-based, biochemical, and physical science-based …
Cell-based drug delivery
Drug delivery has been greatly improved over the years by means of chemical and physical
agents that increase bioavailability, improve pharmacokinetic and reduce toxicities. At the …
agents that increase bioavailability, improve pharmacokinetic and reduce toxicities. At the …
Nanostructures for the inhibition of viral infections
Multivalent interactions are omnipresent in biology and confer biological systems with
dramatically enhanced affinities towards different receptors. Such multivalent binding …
dramatically enhanced affinities towards different receptors. Such multivalent binding …
Drug, enzyme and peptide delivery using erythrocytes as carriers
CG Millan, MLS Marinero, AZ Castaneda… - Journal of controlled …, 2004 - Elsevier
Erythrocytes are potential biocompatible vectors for different bioactive substances, including
drugs. These can be used successfully as biological carriers of drugs, enzymes and …
drugs. These can be used successfully as biological carriers of drugs, enzymes and …
Delivery systems to increase the selectivity of antibiotics in phagocytic cells
E Briones, CI Colino, JM Lanao - Journal of Controlled Release, 2008 - Elsevier
Many infectious diseases are caused by facultative organisms that are able to survive in
phagocytic cells. The intracellular location of these microorganisms protects them from the …
phagocytic cells. The intracellular location of these microorganisms protects them from the …
Applications of carrier erythrocytes in delivery of biopharmaceuticals
M Hamidi, A Zarrin, M Foroozesh… - Journal of controlled …, 2007 - Elsevier
Carrier erythrocytes, resealed erythrocytes loaded by a drug or other therapeutic agents,
have been exploited extensively in recent years for both temporally and spatially controlled …
have been exploited extensively in recent years for both temporally and spatially controlled …
Phosphonomethoxyalkyl analogs of nucleotides
A Holy - Current pharmaceutical design, 2003 - ingentaconnect.com
Acyclic nucleoside phosphonates (ANP) are analogs of nucleotides exhibiting various
biological (eg antiviral, cytostatic, antiparasitic, immunomodulatory) activities. This review …
biological (eg antiviral, cytostatic, antiparasitic, immunomodulatory) activities. This review …
Cell‐based drug delivery and use of nano‐and microcarriers for cell functionalization
Cell functionalization with recently developed various nano‐and microcarriers for
therapeutics has significantly expanded the application of cell therapy and targeted drug …
therapeutics has significantly expanded the application of cell therapy and targeted drug …